Molecular Vision Laboratory implements VarSome Clinical in its diagnostic workflow

Posted by Tomas Kucera on May 21, 2019 4:28:06 PM

Lausanne, May 21th, 2019. Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of advanced bioinformatics solutions, announced today a partnership with Molecular Vision Laboratory (MVL), a CAP and CLIA-certified medical diagnostic laboratory based in Oregon, USA, providing comprehensive genetic NGS-based testing for inherited retinal dystrophies.

PMKB now available on VarSome!

Posted by Tomas Kucera on Jan 10, 2019 2:22:41 PM

New York and Lausanne, Switzerland - January 10, 2019 - Saphetor SA, the creator of VarSome, announced today a partnership with the Englander Institute for Precision Medicine at Weill Cornell Medicine, the creator of Precision Medicine Knowledgebase (PMKB), a curated resource for the clinical interpretation of cancer variants [1]. PMKB is now a fundamental component of VarSome’s portfolio of over 30 integrated and cross-referenced public data resources as well as VarSome’s implementation of the American College of Medical Genetics guidelines.

HPST to distribute VarSome Clinical in the Czech Republic

Posted by Tomas Kucera on Nov 20, 2018 11:37:31 AM

Lausanne, Switzerland - November 20, 2018 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a partnership with HPST, s.r.o., an authorized distributor of Agilent Technologies for the Czech Republic. Saphetor’s clinically-certified platform for fast and accurate variant discovery, annotation, and interpretation of NGS data for whole genomes, exomes, and gene panels extends HPST portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.

Saphetor and DNAnexus collaboratation

Posted by Andreas Massouras on Aug 25, 2017 8:14:00 PM

Saphetor has teamed up with DNAnexus, a leading global genomic cloud services provider in sharing and management of genomic data and tools to accelerate genomics, to build a sample-in, report-out genomic analysis solution. The DNAnexus cloud-based platform is optimized to address the challenges of security, scalability, and collaboration, for organizations that are pursuing genomic-based approaches to health, in the clinic and in the research lab. Saphetor’s technology is now available on the DNAnexus cloud-based platform.

Multiple agreements with University College London

Posted by Andreas Massouras on Jun 1, 2017 8:20:00 PM

LAUSANNE, Switzerland – May 25th 2017 – Saphetor, SA, a Swiss precision medicine company dedicated to advancing personalized diagnostics based on next-generation DNA sequencing, announced today a research partnership with the Exome Consortium of University College London (UCL), led by Dr. Vincent Plagnol.